Conversion therapy using S1/paclitaxel chemotherapy plus apatinib in unresectable gastric cancer: Updated data from a phase II trial
| Autor: | Guofa Yu, Zhiyuan Xu, Xiangdong Cheng, Ping Hu, Conggang Hu, Yian Du |
|---|---|
| Rok vydání: | 2018 |
| Předmět: |
Oncology
Cancer Research Chemotherapy medicine.medical_specialty business.industry medicine.medical_treatment Cancer 030204 cardiovascular system & hematology medicine.disease Clinical trial 03 medical and health sciences chemistry.chemical_compound 0302 clinical medicine chemistry Paclitaxel 030220 oncology & carcinogenesis Internal medicine medicine Apatinib business |
| Zdroj: | Journal of Clinical Oncology. 36:e16010-e16010 |
| ISSN: | 1527-7755 0732-183X |
| DOI: | 10.1200/jco.2018.36.15_suppl.e16010 |
| Popis: | e16010Background: Ahead-G325 trial (ClinicalTrials.gov: NCT02529878) is a multicentre, single-arm phase II clinical trial to investigate application of S1/paclitaxel chemotherapy plus apatinib, an ... |
| Databáze: | OpenAIRE |
| Externí odkaz: |
|